OMALIZUMAB
Omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device
OMALIZUMAB (14950W)
14950W
Manner of administration:Injection
Restriction
Indication: Uncontrolled severe asthma
Treatment phase: Continuing treatment
